Induction of potent TRAIL-mediated tumoricidal activity by hFlex/furin/TRAIL recombinant DNA construct]

Molecular Therapy

Volumn 9, Issue 5, 2004, Pages 674-681

  Wu, Xiaofeng ^a   Hui, Kam M ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Anti tumor activity; Flt3L (hFLex); Furin; Fusagene; TRAIL

Indexed keywords

FLT3 LIGAND; FURIN; LIPOSOME; RECOMBINANT DNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA SEQUENCE; DRUG POTENCY; FEMALE; FLOW CYTOMETRY; GENE CONSTRUCT; GENE EXPRESSION; GENE INSERTION; GENETIC CODE; GENETIC TRANSFECTION; GOLGI COMPLEX; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NASOPHARYNX TUMOR; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; TUMOR CELL; WESTERN BLOTTING; XENOGRAFT;

INSERTION SEQUENCES;

EID: 2442710211     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.02.021     Document Type: Article

References (28)

1. Smyth, M. J., Takeda, K., Hayakawa, Y., Peschon, J. J., van den Brink, M. R., and Yagita, H. (2003). Nature's TRAIL - on a path to cancer immunotherapy. Immunity 18: 1-6.
2. Van Ophoven, A., Ng, C. P., Patel, B., Bonavida, B., and Belldegrun, A. (1999). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literature. Prostate Cancer Prostatic Dis. 2: 227-233.
3. Naka, T., Sugamura, K., Hylander, B. L., Widmer, M. B., Rustum, Y. M., and Repasky, E. A. (2002). Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. Cancer Res. 62: 5800-5806.
4. Roth, W., et al. (1999). Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem. Biophys. Res. Commun. 265: 479-483.
5. Walczak, H., et al. (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5: 157-163.
6. Takeda, K., et al. (2001). Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Cell. Immunol. 214: 194-200.
7. Ashkenazi, A., et al. (1999). Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104: 155-162.
8. Jo, M., et al. (2000). Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat. Med. 6: 564-567.
9. Armeanu, S., et al. (2003). Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Cancer Res. 63: 2369-2372.
10. Lawrence, D., et al. (2001). Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat. Med. 7: 383-385.
11. Wu, X., He, Y., Falo, L. D. Jr., Hui, K. M., and Huang, L. (2001). Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex - TRAIL fusion protein. Mol. Ther. 3: 368-374.
12. Labarrière, N., et al. (2002). Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen. Int. J. Cancer. 101: 280-286.
13. Fonteneau, J.-F., Larsson, M., and Bhardwaj, N. (2002). Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses. Curr. Opin. Immunol. 14: 1-7.
14. Sasaki, S., Amara, R. R., Oran, A. E., Smith, J. M., and Robinson, H. L. (2001). Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nat. Biotechnol. 19: 543-547.
15. + T cells for efficient tumor cell lysis. Cancer Res. 60: 4446-4452.
16. Fong, C. L., and Hui, K. M. (2002). Generation of potent and specific cellular immune responses via in vivo stimulation of dendritic cells by pNGVL3-hFLex plasmid DNA and immunogenic peptides. Gene Ther. 9: 1127-1138.
17. Bresnahan, P. A., et al. (1990). Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo. J. Cell Biol. 111: 2851-2859.
18. Hosaka, M., et al. (1991). Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretary pathway. J. Biol. Chem. 266: 12127-12130.
19. Gäken, J., et al. (2000). Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron. Gene Ther. 23: 1979-1985.
20. Liu, F., Song, Y., and Liu, D. (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6: 1258-1266.
21. Bass, J., Turck, C., Rouard, A., and Steiner, D. F. (2000). Furin-mediated processing in the early secretary pathway: sequential cleavage and degradation of misfolded insulin receptors. Proc. Natl. Acad. Sci. USA 97: 11905-11909.
22. He, Y., Pimenov, A. A., Nayak, J. V., Plowey, J., Falo, L. D. Jr., and Huang, L. (2000). Intravenous injection of naked DNA encoding secreted flt3L ligand dramatically increases the number of dendritic cells and natural killer cells in vivo. Hum. Gene Ther. 11: 547-554.
23. Gao, H., and Hui, K. M. (2001). Synthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives. Gene Ther. 8: 855-863.
24. Leverkus, M., et al. (2000). Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res. 60: 553-559.
25. Wiley, S. R., et al. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682.
26. Nitsch, B., et al. (2000). Human brain death induced by tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet 356: 827-828.
27. Qin, J. Z., Chavurvedi, V., Bonish, B., and Nickoloff, B, J. (2001). Avoiding premature apoptosis of normal epidermal cells. Nat. Med. 7: 385-386.
28. Ng, A., Tang, J. P., Goh, Christopher H.K., and Hui, K. M. (2003). Regulation of the H19 imprinting gene expression in human nasopharyngeal carcinoma by methylation. Int. J. Cancer 104: 179-187.